BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Primary Gr-1+ BCR-ABL1T315I+ myeloid cells (P = 0.0306, Fig. 3c) and total GFP+ BM cells (P = 0.0021, Fig. 3d) from CML mice also revealed significantly increased expression of integrin β3.